Paul Devroey
Devroey, Paul
VIAF ID: 71317983 (Personal)
Permalink: http://viaf.org/viaf/71317983
Preferred Forms
-
-
- 100 1 _ ‡a Devroey, Paul
-
-
- 100 1 _ ‡a Devroey, Paul
- 100 1 _ ‡a Devroey, Paul
- 100 1 _ ‡a Devroey, Paul
- 100 0 _ ‡a Paul Devroey
4xx's: Alternate Name Forms (3)
Works
Title | Sources |
---|---|
adviezen van het Belgisch Raadgevend Comité voor Bio-ethiek 2005-2009 | |
Baby-making | |
Beschikken over lijf en leven : ethische vragen rond vrijheid en geborgenheid | |
Current theory and practice of ICSI | |
Genetics and assisted human conception, 1996: | |
GnRH analogues | |
Laparoscopy and hysteroscopy | |
Obstetric outcome of pregnancies after the transfer of cryopreserved and fresh embryos obtained by conventional in-vitro fertilization and intracytoplasmic sperm injection | |
Oestradiol valerate pretreatment in GnRH-antagonist cycles: a randomized controlled trial. | |
Offering excess oocyte aspiration and vitrification to patients undergoing stimulated artificial insemination cycles can reduce the multiple pregnancy risk and accumulate oocytes for later use. | |
Oocyte and embryo donation: evaluation of 412 consecutive trials | |
Oocyte and embryo quality as well as pregnancy rate in intracytoplasmic sperm injection are not affected by high follicular phase serum progesterone. | |
Oocyte cryopreservation for age-related fertility loss | |
Oocyte donation in patients without ovarian function | |
Outcome for donors and recipients in two egg-sharing policies. | |
Outcome of closed blastocyst vitrification in relation to blastocyst quality: evaluation of 759 warming cycles in a single-embryo transfer policy | |
Ovarian adhesions impair ovulation | |
Ovarian hyperstimulation syndrome: review and new classification criteria for reporting in clinical trials | |
Ovarian stimulation regimens in women with endometriosis | |
Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group | |
Ovulation by repeated human chorionic gonadotrophin in 'empty follicle syndrome' yields a twin clinical pregnancy. | |
Ovulation induction disrupts luteal phase function | |
Patients with absolutely immotile spermatozoa and intracytoplasmic sperm injection. | |
Pelvic inflammatory disease due to Pseudomonas fluorescens in patient wearing an intrauterine device | |
Pentoxifylline in idiopathic male-factor infertility: a review of its therapeutic efficacy after oral administration | |
Pentoxifylline is not useful in enhancing sperm function in cases with previous in vitro fertilization failure. | |
Performance of different embryo transfer catheters in a human in vitro fertilization program | |
Perinatal outcome of pregnancy after GnRH antagonist (ganirelix) treatment during ovarian stimulation for conventional IVF or ICSI: a preliminary report | |
Perurethral ultrasound-guided ovum pickup | |
PGD for aneuploidy screening: an expensive hoax? | |
PGD in 47,XXY Klinefelter's syndrome patients | |
Pharmacodynamics of a single low dose of long-acting recombinant follicle-stimulating hormone (FSH-carboxy terminal peptide, corifollitropin alfa) in women with World Health Organization group II anovulatory infertility | |
Pituitary gonadotrophin secretory capacity during the luteal phase in superovulation using GnRH-agonists and HMG in a desensitization or flare-up protocol. | |
Plasma and follicular fluid concentrations of LHRH antagonist cetrorelix (Cetrotide) in controlled ovarian stimulation for IVF. | |
Pneumoperitoneum induced pH changes in follicular and Douglas fluids during laparoscopic oocyte retrieval in humans. | |
Polymerase chain reaction analysis of the cystic fibrosis delta F508 mutation in human blastomeres following oocyte injection of a single sperm from a carrier. | |
Predicting the FSH threshold dose in women with WHO Group II anovulatory infertility failing to ovulate or conceive on clomiphene citrate | |
Prediction of Ovarian Hyperstimulation Syndrome in Patients Treated with Corifollitropin alfa or rFSH in a GnRH Antagonist Protocol | |
Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation | |
Pregnancies without corpus luteum rescue | |
Pregnancy after zygote intra-fallopian transfer using spermatozoa from a patient with Kallmann's syndrome | |
Pregnancy and birth after intracytoplasmic sperm injection of in vitro matured germinal-vesicle stage oocytes: case report. | |
Pregnancy and birth in an in-vitro fertilization cycle after controlled ovarian stimulation in a woman with a history of allergic reaction to human menopausal gonadotrophin | |
Pregnancy in a couple with a male partner born with severe bladder exstrophy | |
Pregnancy outcome and neonatal data of children born after ICSI using testicular sperm in obstructive and non-obstructive azoospermia | |
Pregnancy prediction in single embryo transfer cycles after ICSI using QPCR: validation in oocytes from the same cohort | |
Preimplantation diagnosis for X and Y normality in embryos from three Klinefelter patients. | |
Preimplantation genetic diagnosis for neurofibromatosis type 1 | |
Preimplantation genetic screening does not improve delivery rate in women under the age of 36 following single-embryo transfer. | |
Prenatal genetic testing by amniocentesis appears to result in a lower risk of fetal loss than chorionic villus sampling in singleton pregnancies achieved by intracytoplasmic sperm injection | |
Prenatal testing in ICSI pregnancies: incidence of chromosomal anomalies in 1586 karyotypes and relation to sperm parameters | |
Preparation of endometrium for egg donation | |
Preserving the reproductive potential of men and boys with cancer: current concepts and future prospects | |
Prevalence of unsuspected uterine cavity abnormalities diagnosed by office hysteroscopy prior to in vitro fertilization. | |
Primary ovarian failure. Embryo donation after substitution therapy | |
Primary ovarian insufficiency | |
Principal findings from a multicenter trial investigating the safety of follicular-fluid meiosis-activating sterol for in vitro maturation of human cumulus-enclosed oocytes. | |
Profound LH suppression after GnRH antagonist administration is associated with a significantly higher ongoing pregnancy rate in IVF. | |
Progesterone administration in patients with absent ovaries | |
Progesterone for the luteal support of assisted reproductive technologies: clinical options | |
Progesterone rise on HCG day in GnRH antagonist/rFSH stimulated cycles affects endometrial gene expression | |
Progesterone rise on the day of human chorionic gonadotropin administration impairs pregnancy outcome in day 3 single-embryo transfer, while has no effect on day 5 single blastocyst transfer. | |
Prognostic factors for delivery in patients undergoing repeated preimplantation genetic aneuploidy screening | |
Prolongation of follicular phase by delaying hCG administration results in a higher incidence of endometrial advancement on the day of oocyte retrieval in GnRH antagonist cycles. | |
Prolongation of the follicular phase in in vitro fertilization results in a lower ongoing pregnancy rate in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists | |
Propofol concentrations in follicular fluid during general anaesthesia for transvaginal oocyte retrieval | |
Prospective, auto-controlled study on reinsemination of failed-fertilized oocytes by intracytoplasmic sperm injection. | |
Prospective follow-up of 838 fetuses conceived after ovarian stimulation with corifollitropin alfa: comparative and overall neonatal outcome. | |
I. The moral status of the pre-implantation embryo. |